Skip to content

Developing and Validating VR-Enabled Ophthalmic Clinics: A New Paradigm for Visual Function Testing

Developing and Validating VR-Enabled Ophthalmic Clinics: A New Paradigm for Visual Function Testing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04530773
Enrollment
36
Registered
2020-08-28
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Health of Virtual Reality

Brief summary

This study aimed to design and validate a VR-based ophthalmic clinic that replicates traditional tests of visual acuity, stereopsis, and contrast sensitivity within an immersive digital environment. Using a rigorously developed system based onprogrammable interfaces, and standardized testing paradigms, we compared VR assessments against gold-standard clinical tools in a cohort of healthy adult participants. Key outcomes included test consistency, correlation, user acceptability, visual fatigue, and time efficiency. Our findings offer evidence for the viability of VR as a platform for remote ophthalmic testing and pave the way for scalable digital eye care delivery.

Interventions

BEHAVIORALWatch VR movies/ Play VR games

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* The study included healthy individuals older than 18 years of age with a best-corrected visual acuity (BCVA) of \<0.1 logarithm of minimum angle of resolution (logMAR) and no ongoing or prior history of ocular or systemic disease.

Exclusion criteria

* The study excluded healthy individuals younger than 18 years of age with a best-corrected visual acuity (BCVA) of \>0.1 logarithm of minimum angle of resolution (logMAR) with ongoing or prior history of ocular or systemic disease.

Design outcomes

Primary

MeasureTime frameDescription
Accommodative Response60 minThe actual amount of accommodation that exists is measured with a skiascope
AC/A Ratio60 minThe ratio of accommodation convergence to accommodation is measured and calculated by maddox

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026